openPR Logo
Press release

Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol Sales?

01-18-2019 03:04 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol

The cannabidiol marketplace is likely to witness significant R&D investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or moving ahead in the human clinical trials. For instance, INSYS Therapeutics, Inc. announced in March 2018, the initiation of Phase III clinical trial of cannabidiol oral solution for the treatment of a rare type of pediatric epilepsy, infantile spasms. GW Pharmaceutical plc and Greenwich Biosciences, GW’s subsidiary announced FDA’s approval of EPIDIOLEX® cannabidiol oral solution in June 2018 and from November 2018, the plant-derived cannabidiol is available by prescription in the U.S.

Approval of EPIDIOLEX® cannabidiol has become a landmark announcement as it is FDA’s very first approval of the drug derived from cannabis sativa plant and also validated some of the therapeutic benefits of cannabidiol. Further, the approval is expected to impact significant economic, political and legislative shifts across the global cannabinoid marketplace. Also, the Drug Enforcement Administration (DEA) is also expected to reschedule and change the classification of cannabidiol compound in the near future.

Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=735 

Increasing CBD Sales: Regulatory Changes Regarding Industrial Hemp to Reduce THC Content & Cost of CBD

Cannabidiol (CBD) is a non-intoxicating and non-psychotropic cannabinoid, which not only imparts myriad beneficial health effects, but also is deprived of relevant side effects. CBD is industrial hemp’s primary cannabinoid, present in concentrations between the range 0.5% and 4%. Major stakeholders in the hemp industry have been focusing on continued growth, in tandem with progress being made in legislature and product development.

The Industrial Hemp Regulations (IHR) address specific topics apropos of the production, processing, control, and export measures within various stages of the industry. Current IHR require two conformances namely, tetrahydrocannabinol (THC) testing of every field, except cultivars depicting low THC in provided province, and THC sampling & testing in production process concerning food derivatives. These process are expensive and entail the need for significant administrative investments by health regulatory bodies.

Recognizing the concern, the Canadian Hemp Trade Alliance (CHTA) proposed an efficient infield science-based alternative for generating reliable results. The proposal involves elimination of THC testing with respect to food derivatives. The alterations suggested are expected to aid achieving the objective of reducing THC content in crops with relatively less investment. Such regulatory changes are further expected to facilitate harvest, processing, and sales of non-psychoactive cannabinoids such as CBD from industrial hemp.

Request Full Report With TOC: https://www.factmr.com/connectus/sample?flag=T&rep_id=735 

Improving Accessibility to CBD-based Therapies: WHO Report aids Alleviation of Restrictions on Cannabidiol

Cannabis comprises over 100 chemical compounds known as cannabinoids, with the most common among them being CBD and THC. The WHO’s Expert Committee on Drug Dependence (ECDD) published a report in 2017, which acknowledges clinical employment of CBD to be the most advanced treatment of epilepsy.

CBD is perceived to have significant therapeutic value for seizures on account of epilepsy and relevant conditions. In addition, clinical trials conducted on CBD have depicted its efficacy in treatment of various forms of epilepsy. The report further acknowledged existence of primary evidence underpinning utilization of CBD in treatment and management of various other diseases that include Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, rheumatoid arthritis, Crohn’s disease and Huntington’s disease.

ECDD’s conclusion states that current state of research with regard to scheduling of CBD is not justified, and it could impact accessibility for medical and scientific research. ECDD’s impending final recommendations, to be published soon, will reaffirm or reinforce these conclusions, in order to alleviate legitimate basis for Secretary of Department of Health in maintaining present restrictions on CBD. This will not only relieve burden from companies developing medicinal products, but also improve access for consumers to effective and novel therapies.

Cannabidiol Market: Surging Penetration in Health Food Products

Rich in alpha-linoleic, linoleic, and antioxidants, CBD oil illustrates optimal ratio of Omega-6 and Omega-3 fatty acids. Numerous studies underpin the fact that properties of CBD assist management of depression & anxiety, pain, seizures, and insomnia. As researchers continue to analyze this increasingly popular cannabinoid, consumers across the globe are becoming more aware of the therapeutic qualities associated with CBD.

Based on preferences, circumstances, and conditions of an individual, there are various ways in which CBD can be consumed, with some of the valid options being vaping CBD oil, applying CBD ointment topically, and swallowing CBD capsules. Currently, more and more individuals are seeking incorporation of CBD into their lifestyle through infusion into their meals.

CBD-infused food products are gaining high momentum in the market, abreast growing consumer demand for healthy food options. In response to growing demand, companies are concentrating on production of healthy foods for meeting requirements of consumers seeking healthy replacements for traditional CBD-infused foods. Some of the common examples of such healthy alternatives include essential oil blends, flavored tinctures, and edibles such as coffee and candy.

Notable Developments in CBD Market

Pivot Pharmaceuticals Inc., in coordination with SolMic GmbH, its German technology partner, announced the initiation of its development of PGS-N001 in 2017. PGS-N001 is a water-soluble, natural, and pure oral CBD solution, which shows highest bioavailability and is devoid of THC. PGS-N001 will be developed and formulated for treating a wide range of disease indications such as the chemotherapy-induced nausea and vomiting (CINV) – major therapeutic challenge in cancer supportive care area.
Nightfood Holdings, a startup that manufactures and markets products in nighttime snacking category, entered into a joint venture with Player’s Network Inc. in 2017. This joint venture is dedicated toward the development of CBD-infused line of products such as cannabinoid oil.
Marijuana Company of America, Inc. (MCOA) has partnered with HoneyB Healthy Living for developing a series of CBD-based products. These products will be launched under the brand name “BeniHemp” and are intended to be distributed through convenience stores. The partnership aims at full-scale launch of their new product series by 2018-end, while coordinating supply chain arrangements via their partners in Colorado.

Grow Your Business From Expert Advice: https://www.factmr.com/report/735/cannabidiol-market 

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol Sales? here

News-ID: 1513250 • Views: 235

More Releases from Fact.MR

Application Preference from Machine Tools and General Automation Stimulating Sal …
Fact.MR has recently published a new study titled “Piezoelectric Motor Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2027”, which discusses the overall growth expected across the piezoelectric motor market during the period until 2027. It is discoursed that the development of new devices and equipment in diverse industries have motivated the application of piezoelectric motors specifically across the micro positioning stages. The demand for
Global Gardening Equipment Market Scenario Highlighting Major Drivers & Trends, …
In order to dissert the market scenario prevailing across the gardening equipment market sector, Fact.MR has evenly presented a comprehensive analysis report on gardening equipment market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the gardening equipment market in the coming years. In
Global Fuel Card Market Expectations & Growth Trends Highlighted until 2028 | Ke …
In order to dissert the market scenario prevailing across the fuel card market sector, Fact.MR has evenly presented a comprehensive analysis report on fuel card market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the fuel card market in the coming years. In
Dry Type Dust Control Systems Market Insights, Trends & Future Development Statu …
The purpose of this comprehensive forecast report presented by Fact.MR is to elaborate the various market projections impacting the global dry type dust control systems market size during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are

All 5 Releases


More Releases for CBD

CBD Oil Market Future Growth Prospect and Trends 2025 by Top Key Players IRIE CB …
The CBD Oil Market is continuously growing in the global scenario at significant pace. CBD is one of the hundreds of cannabinoids found in the Cannabis sativa plant. CBD can be derived from two different species of cannabinoids: marijuana and hemp. Growing awareness about benefits of CBD oil among people and worldwide expansion of young population are the substantial driving factors of the market during the forecast period. The CBD
CBD Oil Market Massive Growth and Demand with Top Key Players: IRIE CBD, Elixino …
The CBD Oil Market is continuously growing in the global scenario at significant pace. CBD is one of the hundreds of cannabinoids found in the Cannabis sativa plant. CBD can be derived from two different species of cannabinoids: marijuana and hemp. Growing awareness about benefits of CBD oil among people and worldwide expansion of young population are the substantial driving factors of the market during the forecast period. In addition
Sydney CBD Medical Centre
Our mission is to provide the highest standard care to you and your family. We are committed to promote well being and disease prevention. We pride ourselves on our services and our doctors are continually pursuing excellence in medicine and surgery through their work and study. This is a fully accredited medical centre under the standards set by the Royal Australian College of General Practitioners and also NSW Health Dept
F2P Industries Creates Groundbreaking CBD Product
[DENVER, COLORADO] With the dramatic rise in the popularity of CBD, innovation is booming. Colorado-based F2P Industries has just entered the market in a big way with the launch of a powerhouse lineup of CBD products that address aches, pain, inflammation, anxiety and digestive disorders. F2P Industries is focused on creating products that are effective, natural, empowering, consistently reliable and unquestionably life-changing. Between the company’s commitment to sustainability and its use
Global CBD Oil Market 2018 | Major Kay Players – ENDOCA, Isodiol, Medical Mari …
WiseGuyRerports.com Presents “Global CBD Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” New Document to its Studies Database Hemp oil extracts have traditionally been used around the globe as medicine. A large body of evidence has indicated that the benefits of CBD hemp oil can relieve various ailments. Endoca maintains the biochemical equilibrium within the hemp plants to maximize the beneficial effects of its organic CBD oil. Scope
CBD Hemp Oil Market Is Booming Worldwide | ENDOCA, CBD American Shaman, Gaia Bot …
HTF Market Intelligence released a new research report of 116 pages on title 'France CBD Hemp Oil Market Report 2018 with detailed analysis, forecast and strategies. The study covers key regions that includes and important players such as ENDOCA, CBD American Shaman, Gaia Botanicals, Isodiol, Medical Marijuana, Aurora Cannabis (AC) Request a sample report @ https://www.htfmarketreport.com/sample-report/1340907-france-cbd-hemp-oil-market Summary with the slowdown in world economic growth, the CBD Hemp Oil industry has also